Tag: SAHPRA
Heberon acquisition wasted R260 million
The Department of Defence’s acquisition of R260 million worth of Heberon from Cuba to treat COVID-19 patients was for nought as the drug is...
SANDF misses Public Protector Interferon deadline
It appears the senior command structure of the national defence force is not an active participant into an ongoing Public Protector (PP) investigation of...
More questions than answers on Cuban COVID-19 drug
The apparent illegal importing of a Cuban drug to strengthen soldiers’ resistance to COVID-19 came – unsatisfactorily – under the Parliamentary oversight microscope on...
